caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1578652988

Carol ShieldsMD

PRACTICESHIELDS AND SHIELDS PCSee all providers at this practice →
OphthalmologyPhiladelphia, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Carol Shields's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
TENET HEALTH SYSTEM HAHNEMANN, LLC4952
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Norristown, PA
4473
Laboratory Corporation Of America Holdings
Clinical Laboratory · Raritan, NJ
4265
Lydia Komarnicky
Radiation Oncology · Philadelphia, PA
39136
THOMAS JEFFERSON UNIVERSITY HOSPITALS INC2742
NPI 13564802891112
Miriam Zentner
Anesthesiology · Philadelphia, PA
1111
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
6,822
Unique beneficiaries
—
Total services
8,213
Distinct HCPCS
30
Medicare payment
$611K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 810 Ophthalmology providers in PA — top quintile (cohort median 1,854).
PRESCRIBING · PART D · 2024
Total Rx claims
579
Beneficiaries
—
Total drug cost
$7K
Distinct drugs
9
Brand share
72.4%
Top prescribed drugs
Neomycin/Polymyxin B/Dexametha262 claims
Atropine Sulfate97 claims
Ondansetron61 claims
Erythromycin Base60 claims
Lorazepam40 claims
QUALITY · MIPS · 2024
Final MIPS score
71.1
Quality
50.8
Cost
0.0
Improvement activities
40.0
Promoting interop.
94.0
Payment adjustment
-0.47%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$1K
Payment records
2
By payment type
Consulting Fee$1K
Food and Beverage$22